ATE194283T1 - Naphtochinonderivate zur behandlung von chronischen entzündungen - Google Patents
Naphtochinonderivate zur behandlung von chronischen entzündungenInfo
- Publication number
- ATE194283T1 ATE194283T1 AT92903652T AT92903652T ATE194283T1 AT E194283 T1 ATE194283 T1 AT E194283T1 AT 92903652 T AT92903652 T AT 92903652T AT 92903652 T AT92903652 T AT 92903652T AT E194283 T1 ATE194283 T1 AT E194283T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- menadione
- treatment
- chronic inflammation
- sec
- Prior art date
Links
- 208000037976 chronic inflammation Diseases 0.000 title 1
- 230000006020 chronic inflammation Effects 0.000 title 1
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-dioxonaphthalene Natural products C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 abstract 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- NNUKDUBCRRYXDC-UHFFFAOYSA-N 1a-methyl-7ah-naphtho[2,3-b]oxirene-2,7-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2(C)C1O2 NNUKDUBCRRYXDC-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- WIXFIQKTHUVFDI-UHFFFAOYSA-N menadione sulfonic acid Chemical compound C1=CC=C2C(=O)C(C)(S(O)(=O)=O)CC(=O)C2=C1 WIXFIQKTHUVFDI-UHFFFAOYSA-N 0.000 abstract 1
- 235000012711 vitamin K3 Nutrition 0.000 abstract 1
- 239000011652 vitamin K3 Substances 0.000 abstract 1
- 229940041603 vitamin k 3 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102340A GB9102340D0 (en) | 1991-02-04 | 1991-02-04 | Therapeutic compounds |
| GB919124541A GB9124541D0 (en) | 1991-11-19 | 1991-11-19 | Therapeutic compounds |
| PCT/GB1992/000196 WO1992013532A2 (en) | 1991-02-04 | 1992-02-03 | Naphthoquinone derivatives for the treatment of chronic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE194283T1 true ATE194283T1 (de) | 2000-07-15 |
Family
ID=26298390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92903652T ATE194283T1 (de) | 1991-02-04 | 1992-02-03 | Naphtochinonderivate zur behandlung von chronischen entzündungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5763479A (de) |
| EP (1) | EP0570414B1 (de) |
| JP (1) | JP3251582B2 (de) |
| AT (1) | ATE194283T1 (de) |
| AU (1) | AU1195092A (de) |
| DE (1) | DE69231222T2 (de) |
| DK (1) | DK0570414T3 (de) |
| ES (1) | ES2149168T3 (de) |
| GR (1) | GR3034445T3 (de) |
| WO (1) | WO1992013532A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2149633C1 (ru) * | 1999-09-01 | 2000-05-27 | Хачатрян Ашот Папикович | Способ лечения иммунодефицитных состояний организма |
| DE60135732D1 (de) * | 2000-02-28 | 2008-10-23 | Univ British Columbia | Topoisomerasehemmern zur behandlung von chirurgischen verklebungen |
| GB0104571D0 (en) * | 2001-02-23 | 2001-04-11 | Ks Biomedix Holdings Plc | Composition |
| GB0117326D0 (en) * | 2001-07-16 | 2001-09-05 | Univ Aberdeen | Napthoquinone-type inhibitors of protein aggregation |
| WO2004042353A2 (en) * | 2002-10-30 | 2004-05-21 | Galileo Pharmaceuticals, Inc. | Identifying therapeutic compounds based on their physical-chemical properties |
| ITMI20031011A1 (it) * | 2003-05-20 | 2004-11-21 | Vanetta S P A | Composti biocidi per il trattamento delle acque. |
| US20070009450A1 (en) * | 2004-09-03 | 2007-01-11 | Susanne Emig | Preparation, in particular cosmetic preparation, process for the... |
| KR100769708B1 (ko) | 2006-09-21 | 2007-10-23 | 한국생명공학연구원 | 살충활성을 갖는 설포닐 나프토퀴논류 화합물들의유기합성방법과 살충제 이용 기술 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2367302A (en) * | 1940-03-25 | 1945-01-16 | Abbott Lab | Bisulphite derivatives of 2-methyl-1, 4-naphthoquinone and the like |
| US3821408A (en) | 1972-12-26 | 1974-06-28 | American Cyanamid Co | Compositions of sulfonium ylides and method of use |
| DE3347658A1 (de) * | 1983-12-31 | 1985-07-11 | Troponwerke GmbH & Co KG, 5000 Köln | 1.4-naphthochinonderivate mit entzuendungshemmender wirkung |
-
1992
- 1992-02-03 US US08/087,743 patent/US5763479A/en not_active Expired - Fee Related
- 1992-02-03 JP JP50402692A patent/JP3251582B2/ja not_active Expired - Fee Related
- 1992-02-03 DE DE69231222T patent/DE69231222T2/de not_active Expired - Fee Related
- 1992-02-03 WO PCT/GB1992/000196 patent/WO1992013532A2/en not_active Ceased
- 1992-02-03 AT AT92903652T patent/ATE194283T1/de not_active IP Right Cessation
- 1992-02-03 EP EP92903652A patent/EP0570414B1/de not_active Expired - Lifetime
- 1992-02-03 ES ES92903652T patent/ES2149168T3/es not_active Expired - Lifetime
- 1992-02-03 DK DK92903652T patent/DK0570414T3/da active
- 1992-02-03 AU AU11950/92A patent/AU1195092A/en not_active Abandoned
-
2000
- 2000-09-20 GR GR20000402137T patent/GR3034445T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69231222T2 (de) | 2001-03-01 |
| DK0570414T3 (da) | 2000-11-06 |
| AU1195092A (en) | 1992-09-07 |
| US5763479A (en) | 1998-06-09 |
| EP0570414A1 (de) | 1993-11-24 |
| EP0570414B1 (de) | 2000-07-05 |
| JPH06505005A (ja) | 1994-06-09 |
| GR3034445T3 (en) | 2000-12-29 |
| ES2149168T3 (es) | 2000-11-01 |
| DE69231222D1 (de) | 2000-08-10 |
| JP3251582B2 (ja) | 2002-01-28 |
| WO1992013532A2 (en) | 1992-08-20 |
| WO1992013532A3 (en) | 1992-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0634927T3 (da) | Behandling og profylakse af sygdomme forårsaget af parasitter eller bakterier | |
| BR8906719A (pt) | Composicoes microbiocidas sinergisticas,contendo 2-n-octil-isotiazolona e certos biocidas comerciais | |
| ES2159309T3 (es) | Semillas tratadas. | |
| RU94031102A (ru) | Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний | |
| ES2135083T3 (es) | Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis. | |
| ES2131185T3 (es) | Arilalcanil-n-hidroxiureas y heteroalquilalcanil-n-hidroxiureas sustituidas que pueden inhibir la biosintesis de leucotrienos. | |
| MX9701385A (es) | Preparacion de producto combinado para usarse en enfermedades inmunologicas. | |
| KR930701175A (ko) | 인체 전립선 아데노카르시노마의 치료방법 | |
| ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| DE69231222D1 (de) | Naphtochinonderivate zur Behandlung von chronischen Entzündungen | |
| ES2104358T3 (es) | Inhibidores sililados de acetilcolinesterasa. | |
| DE69713300D1 (de) | Benzopyran derivate mit leukotrien-antagonistischer wirkung | |
| GR3029370T3 (en) | Compounds and methods for inhibition of hiv and related viruses | |
| ATE283044T1 (de) | Compactin zur behandlung von entzündungen | |
| ATE271873T1 (de) | Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz | |
| ATE152913T1 (de) | Biozide zusammensetzung die senfsamenextrakt enthält | |
| ES2053039T3 (es) | Procedimiento para impedir el cambio de color de los alimentos. | |
| ES2066546T3 (es) | Composicion farmaceutica para inhibir la resorcion osea. | |
| ATE100826T1 (de) | Behandlung von celluloseblaettern. | |
| NO20001758L (no) | FremgangsmÕter og blandinger for behandling av leddgikt | |
| FI953002A0 (fi) | Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla | |
| ATE193206T1 (de) | Zusammensetzung zur behandlung oder vorbeugung von herpes | |
| DE69429013D1 (de) | Verwendung von dimeticon zur behandlung der konstipation | |
| DE69108357D1 (de) | Behandlung von verdünnten säurehaltigen Lösungen. | |
| ATE29033T1 (de) | Verwendung von pflanzenextrakten aus der familie der hypoxidaceae zur behandlung von malignen neoplasmen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |